Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xinmai Kang capsule for stable angina (phase II, double-blind RCT)
CTR20130711Phase 2Completed
- Sponsor
- First Affiliated Hospital of Guangxi University of Chinese Medicine
- Start
- Oct 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xinmai Kang capsule in coronary arteriosclerosis, stable angina, sponsored by First Affiliated Hospital of Guangxi University of Chinese Medicine. Started Oct 2013; status: completed.
02
Drugs
Xinmai Kang capsule
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on CTR20130711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130711.